查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2030016

自我檢測市場 - 全球產業規模、佔有率、趨勢、機會及預測：按產品、樣品、應用、分銷管道、用途、地區和競爭對手分類，2021-2031年

Self-Testing Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product, By Sample, By Application, By Distribution Channel, By Usage, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 188 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球自測市場預計將從 2025 年的 117.1 億美元成長到 2031 年的 195.5 億美元，複合年成長率為 8.92%。

這些檢測方案使個人能夠在常規臨床環境之外輕鬆進行診斷評估，從而實現有效的疾病篩檢、持續的自我監測和慢性病管理。該領域的成長主要受慢性病盛行率上升、消費者健康意識增強以及對私密便捷的替代醫療保健方案日益成長的需求所驅動。此外，先進生物感測器和數位連接等創新技術不斷提高檢測準確性和消費者信心。歐洲醫療技術協會（MedTech Europe）的報告顯示，2023年歐洲體外診斷市場（包括自測設備）的銷售額達到133億歐元，這充分體現了該領域的規模。

市場概覽
預測期 2027-2031
市場規模：2025年 117.1億美元
市場規模：2031年 195.5億美元
複合年成長率：2026-2031年 8.92%
成長最快的細分市場 血
最大的市場 北美洲

儘管取得了這些積極進展，但由於法規環境複雜多變，市場仍面臨許多挑戰。歐盟體外診斷醫療設備法規 (IVDR) 尤其體現了這一點，該法規要求提供更嚴格的臨床證據和更全面的技術文件。因此，日益成長的監管壓力可能導致研發投入增加，新產品上市時間延長，最終阻礙創新自檢技術的發展。

市場促進因素

全球自測市場的主要驅動力是感染疾病和慢性病發病率的上升，這推動了對便捷易用的監測和診斷工具的持續需求。由於心血管疾病、糖尿病和感染疾病等疾病需要頻繁的評估和管理，家用檢測套組是快速檢測和日常健康管理的理想選擇。這些健康問題的廣泛性凸顯了自測設備在傳統醫療機構以外的護理管理中的價值。例如，國際糖尿病聯盟（IDF）在2025年4月報告稱，到2024年，全球將有5.89億成年人患有糖尿病。如此龐大的人群高度依賴現代自測檢測套組提供的持續監測和診斷功能。

同時，消費者對去中心化、以患者為中心的醫療保健模式的日益偏好，正在加速推動對便捷居家檢測方案的需求。人們越來越重視居家檢測所提供的隱私性、即時結果以及免去診所就診的便利性。這項轉變的驅動力來自於檢測套組準確性和易用性等技術的進步，這些進步進一步增強了消費者的信心。例如，雅培公司在2025年1月發布的報告顯示，其2024年全球診斷產品銷售額（不包括新冠肺炎）實現了6.1%的有機成長，主要得益於對快速呼吸道檢測的強勁需求。這凸顯了市場對能夠輕鬆融入日常生活的醫療保健解決方案的迫切需求。最終，正是嚴峻的健康挑戰和對便利醫療保健的追求共同推動了市場的發展，國際糖尿病聯盟（IDF）的觀察也印證了這一點：2024年全球糖尿病相關醫療保健支出將首次突破1兆美元。

市場挑戰

應對複雜多變的法規環境仍是全球自檢市場面臨的主要障礙。歐盟體外診斷醫療醫療設備法規 (IVDR) 就是一個典型的例子，該法規對自我檢測設備的臨床認證和技術文件提出了更嚴格的標準。遵守這些嚴格的要求必然會導致研發成本大幅增加，新產品上市時間也顯著延長。

這些嚴格的監管障礙正在減緩整體市場發展勢頭，可能延遲尖端自我檢測技術的上市，並限制這些產品的供應。製造商在努力滿足新的合規要求時，面臨嚴峻的營運挑戰和財務負擔，這些新規要求提交大量文件並進行額外的臨床試驗。 MedTech Europe 2024 年的監管調查凸顯了這個問題，調查顯示，在新框架下，體外診斷醫療設備的認證和維護成本飆升了 100% 以上。此外，預計未來五年，這些器材的製造商將面臨重新認證和維護成本增加 70% 的情況。如此沉重的財務負擔可能會影響新創新的資金投入，最終阻礙產業成長，並可能使消費者無法獲得尖端的診斷解決方案。

市場趨勢

全球自測市場正受到與智慧型手機無縫整合的診斷系統持續發展的顯著影響。這個生態系統使自測設備能夠直接連接個人行動設備，從而實現即時數據收集、結果分析以及與醫療專業人員的資訊共用。這種連接性帶來了方便用戶使用的介面和詳細的數位健康記錄，顯著提升了整體用戶體驗。隨著人們擴大使用行動技術來管理日常生活的方方面面，能夠利用智慧型手機同步功能提供更深入健康洞察的自測產品也日益受到關注。因此，即使在臨床環境之外，患者也能在自身健康管理中扮演更個人化和積極主動的角色。

除了行動連線之外，將人工智慧 (AI) 整合到診斷評估中正成為一項關鍵的市場趨勢。 AI 演算法正擴大被整合到自測系統中，以提高結果分析的速度和準確性。透過評估複雜的健康數據，這些智慧工具能夠產生有意義的見解，並自動識別需要醫生審核的結果，從而減輕人工評估的負擔，並提高測試的可靠性。這項技術飛躍將幫助一般使用者和醫療保健專業人員做出快速且明智的健康選擇。福布斯 2025 年 10 月的一份報告凸顯了這一快速變化，該報告指出，22% 的醫療機構將部署專門的 AI 工具，與 2024 年相比成長了七倍，這凸顯了 AI 在診斷領域的快速普及。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球自我檢測市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（試劑盒、設備、試紙）
    • 檢體類型（血液、尿液、糞便、其他）
    • 依申請項目（血壓測試、糖尿病/血糖測試、膽固醇/三酸甘油酯測試、懷孕測試、性行為感染（STD/STI）測試、尿道感染測試、癌症測試、乳糜瀉測試、甲狀腺測試、轉氨酶測試、貧血測試、過敏測試等）
    • 銷售管道（線上、線下）
    • 依用途（一次性、可重複使用）
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美自我檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲自檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區自檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東與非洲自測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲自檢市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球自我檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • QuidelOrtho Corporation
  • Danaher Corporation
  • bioMerieux SA
  • OraSure Technologies, Inc.
  • SD Biosensor, Inc.
  • ACON Laboratories, Inc.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 14871

The Global self-testing market is anticipated to expand from USD 11.71 billion in 2025 to USD 19.55 billion by 2031, reflecting a compound annual growth rate (CAGR) of 8.92%. These testing solutions empower individuals to conduct diagnostic evaluations comfortably outside of standard clinical environments, facilitating effective disease screening, continuous self-monitoring, and the management of long-term conditions. Growth in this sector is heavily fueled by the rising incidence of chronic ailments, heightened consumer awareness regarding personal health, and an increasing preference for confidential, easy-to-use healthcare alternatives. Additionally, innovations such as advanced biosensors and digital connectivity continue to boost both the precision of these tests and the trust consumers place in them. Highlighting the scale of this sector, MedTech Europe reported that the wider European in vitro diagnostic market, which includes self-testing devices, generated €13.3 billion in revenue in 2023.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 11.71 Billion
Market Size 2031USD 19.55 Billion
CAGR 2026-20318.92%
Fastest Growing SegmentBlood
Largest MarketNorth America

Despite these positive trends, the market faces considerable obstacles due to a complicated and constantly shifting regulatory environment. This is especially true concerning the European Union's In Vitro Diagnostic Medical Devices Regulation (IVDR), which mandates more rigorous clinical evidence and comprehensive technical documentation. Consequently, this elevated regulatory pressure leads to increased research and development expenses as well as prolonged timelines for bringing new products to market, which may ultimately hinder the rollout of novel self-testing technologies.

Market Driver

A major catalyst for the global self-testing market is the rising incidence of infectious and chronic diseases, which drives a continuous demand for user-friendly monitoring and diagnostic resources. Ailments like cardiovascular disorders, diabetes, and infectious illnesses require frequent evaluation and management, making at-home testing kits ideal for prompt detection and routine health tracking. The widespread nature of these health issues emphasizes the value of self-testing devices for managing care beyond traditional medical facilities. For example, the International Diabetes Federation (IDF) reported in April 2025 that 589 million adults were affected by diabetes worldwide in 2024. This massive demographic relies heavily on the steady monitoring and diagnostic capabilities that modern self-testing kits deliver.

At the same time, a growing consumer preference for decentralized, patient-focused healthcare is accelerating the demand for accessible at-home testing options. People increasingly value the privacy, instant results, and elimination of travel that self-administered tests provide. This shift is reinforced by technological improvements that make these kits more accurate and simpler to use, thereby building stronger consumer trust. Illustrating this trend, Abbott reported in January 2025 that its global diagnostics sales, excluding COVID-19, grew by 6.1% organically in 2024, largely fueled by a robust appetite for rapid respiratory testing. This underscores a strong desire for health solutions that fit easily into everyday routines. Ultimately, the combination of substantial health challenges and the pursuit of accessible care is propelling the market forward, as evidenced by the IDF noting that worldwide diabetes-related healthcare spending exceeded one trillion US dollars for the first time in 2024.

Market Challenge

Navigating a complicated and continually changing regulatory environment remains a primary obstacle for the global self-testing market. A prime example is the European Union's In Vitro Diagnostic Medical Devices Regulation (IVDR), which enforces much more rigorous standards regarding clinical proof and technical paperwork for self-testing devices. Complying with these stringent demands inevitably leads to much higher research and development expenditures, alongside significantly longer periods required to bring new products to the commercial market.

These stringent regulatory hurdles slow down overall market momentum by postponing the launch of cutting-edge self-testing technologies and potentially limiting the availability of these products. Manufacturers are encountering intense operational challenges and financial burdens as they attempt to satisfy new compliance rules, which dictate vast amounts of documentation and supplementary clinical trials. Highlighting this issue, MedTech Europe's 2024 Regulatory Survey revealed that costs associated with certifying and maintaining in vitro diagnostic items have surged by 100% or more under the new frameworks. Additionally, producers of these devices are projected to face a 70% increase in expenses for re-certification and upkeep over a five-year period. Such severe financial strain diverts funds away from new innovations, ultimately restricting the sector's growth and depriving consumers of access to state-of-the-art diagnostic solutions.

Market Trends

The Global self-testing market is being heavily shaped by the ongoing development of diagnostic systems that integrate seamlessly with smartphones. Such ecosystems allow self-administered tests to link directly with personal mobile devices, making it easier to collect data in real time, analyze results, and share information with medical professionals. This connectivity significantly improves the overall user experience by providing easy-to-navigate interfaces and maintaining detailed digital health logs. Because people are using mobile technology to organize nearly every facet of their daily routines, there is a surging interest in self-testing products that utilize smartphone syncing to offer deeper health insights. Consequently, patients are empowered to take a more customized and proactive role in managing their well-being away from clinical environments.

Alongside mobile integration, the incorporation of artificial intelligence into diagnostic evaluation is emerging as a vital market trend. AI algorithms are frequently being embedded within self-testing systems to boost the speed and precision of result analysis. By evaluating intricate health data, these intelligent tools can generate meaningful insights and automatically identify outcomes that may need a doctor's review, easing the challenge of manual assessment and raising the reliability of the tests. This technological leap assists both everyday users and medical practitioners in making prompt, well-informed health choices. Highlighting this rapid shift, a Forbes report from October 2025 noted that 22% of healthcare institutions had adopted specialized AI instruments, representing a seven-fold jump from 2024 and emphasizing the swift embrace of artificial intelligence across the diagnostic sector.

Key Market Players

  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthineers AG
  • Becton, Dickinson and Company
  • QuidelOrtho Corporation
  • Danaher Corporation
  • bioMerieux S.A.
  • OraSure Technologies, Inc.
  • SD Biosensor, Inc.
  • ACON Laboratories, Inc.

Report Scope

In this report, the Global Self-Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Self-Testing Market, By Product

  • Kits
  • Devices
  • Strips

Self-Testing Market, By Sample

  • Blood
  • Urine
  • Stool
  • Others

Self-Testing Market, By Application

  • Blood Pressure Test
  • Diabetes and Glucose Tests
  • Cholesterol and Triglycerides Tests
  • Pregnancy Test
  • STD /STI Test
  • Urinary Tract Infection Test
  • Cancer Test
  • Celiac disease Test
  • Thyroid Test
  • Transaminase Test
  • Anemia Test
  • Allergy Test
  • Others

Self-Testing Market, By Distribution Channel

  • Online
  • Offline

Self-Testing Market, By Usage

  • Disposable
  • Reusable

Self-Testing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Self-Testing Market.

Available Customizations:

Global Self-Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Self-Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Kits, Devices, Strips)
    • 5.2.2. By Sample (Blood, Urine, Stool, Others)
    • 5.2.3. By Application (Blood Pressure Test, Diabetes and Glucose Tests, Cholesterol and Triglycerides Tests, Pregnancy Test, STD /STI Test, Urinary Tract Infection Test, Cancer Test, Celiac disease Test, Thyroid Test, Transaminase Test, Anemia Test, Allergy Test, Others)
    • 5.2.4. By Distribution Channel (Online, Offline)
    • 5.2.5. By Usage (Disposable, Reusable)
    • 5.2.6. By Region
    • 5.2.7. By Company (2025)
  • 5.3. Market Map

6. North America Self-Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Sample
    • 6.2.3. By Application
    • 6.2.4. By Distribution Channel
    • 6.2.5. By Usage
    • 6.2.6. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Self-Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Sample
        • 6.3.1.2.3. By Application
        • 6.3.1.2.4. By Distribution Channel
        • 6.3.1.2.5. By Usage
    • 6.3.2. Canada Self-Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Sample
        • 6.3.2.2.3. By Application
        • 6.3.2.2.4. By Distribution Channel
        • 6.3.2.2.5. By Usage
    • 6.3.3. Mexico Self-Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Sample
        • 6.3.3.2.3. By Application
        • 6.3.3.2.4. By Distribution Channel
        • 6.3.3.2.5. By Usage

7. Europe Self-Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Sample
    • 7.2.3. By Application
    • 7.2.4. By Distribution Channel
    • 7.2.5. By Usage
    • 7.2.6. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Self-Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Sample
        • 7.3.1.2.3. By Application
        • 7.3.1.2.4. By Distribution Channel
        • 7.3.1.2.5. By Usage
    • 7.3.2. France Self-Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Sample
        • 7.3.2.2.3. By Application
        • 7.3.2.2.4. By Distribution Channel
        • 7.3.2.2.5. By Usage
    • 7.3.3. United Kingdom Self-Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Sample
        • 7.3.3.2.3. By Application
        • 7.3.3.2.4. By Distribution Channel
        • 7.3.3.2.5. By Usage
    • 7.3.4. Italy Self-Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Sample
        • 7.3.4.2.3. By Application
        • 7.3.4.2.4. By Distribution Channel
        • 7.3.4.2.5. By Usage
    • 7.3.5. Spain Self-Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Sample
        • 7.3.5.2.3. By Application
        • 7.3.5.2.4. By Distribution Channel
        • 7.3.5.2.5. By Usage

8. Asia Pacific Self-Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Sample
    • 8.2.3. By Application
    • 8.2.4. By Distribution Channel
    • 8.2.5. By Usage
    • 8.2.6. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Self-Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Sample
        • 8.3.1.2.3. By Application
        • 8.3.1.2.4. By Distribution Channel
        • 8.3.1.2.5. By Usage
    • 8.3.2. India Self-Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Sample
        • 8.3.2.2.3. By Application
        • 8.3.2.2.4. By Distribution Channel
        • 8.3.2.2.5. By Usage
    • 8.3.3. Japan Self-Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Sample
        • 8.3.3.2.3. By Application
        • 8.3.3.2.4. By Distribution Channel
        • 8.3.3.2.5. By Usage
    • 8.3.4. South Korea Self-Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Sample
        • 8.3.4.2.3. By Application
        • 8.3.4.2.4. By Distribution Channel
        • 8.3.4.2.5. By Usage
    • 8.3.5. Australia Self-Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Sample
        • 8.3.5.2.3. By Application
        • 8.3.5.2.4. By Distribution Channel
        • 8.3.5.2.5. By Usage

9. Middle East & Africa Self-Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Sample
    • 9.2.3. By Application
    • 9.2.4. By Distribution Channel
    • 9.2.5. By Usage
    • 9.2.6. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Self-Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Sample
        • 9.3.1.2.3. By Application
        • 9.3.1.2.4. By Distribution Channel
        • 9.3.1.2.5. By Usage
    • 9.3.2. UAE Self-Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Sample
        • 9.3.2.2.3. By Application
        • 9.3.2.2.4. By Distribution Channel
        • 9.3.2.2.5. By Usage
    • 9.3.3. South Africa Self-Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Sample
        • 9.3.3.2.3. By Application
        • 9.3.3.2.4. By Distribution Channel
        • 9.3.3.2.5. By Usage

10. South America Self-Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Sample
    • 10.2.3. By Application
    • 10.2.4. By Distribution Channel
    • 10.2.5. By Usage
    • 10.2.6. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Self-Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Sample
        • 10.3.1.2.3. By Application
        • 10.3.1.2.4. By Distribution Channel
        • 10.3.1.2.5. By Usage
    • 10.3.2. Colombia Self-Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Sample
        • 10.3.2.2.3. By Application
        • 10.3.2.2.4. By Distribution Channel
        • 10.3.2.2.5. By Usage
    • 10.3.3. Argentina Self-Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Sample
        • 10.3.3.2.3. By Application
        • 10.3.3.2.4. By Distribution Channel
        • 10.3.3.2.5. By Usage

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Self-Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Abbott Laboratories
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. F. Hoffmann-La Roche Ltd.
  • 15.3. Siemens Healthineers AG
  • 15.4. Becton, Dickinson and Company
  • 15.5. QuidelOrtho Corporation
  • 15.6. Danaher Corporation
  • 15.7. bioMerieux S.A.
  • 15.8. OraSure Technologies, Inc.
  • 15.9. SD Biosensor, Inc.
  • 15.10. ACON Laboratories, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer